Resultados de búsqueda - M D Benson
- Mostrando 1 - 19 Resultados de 19
-
1
-
2
-
3
-
4
Transthyretin: a review from a structural perspective por James A. Hamilton, M D Benson
Publicado 2001Revisão -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30–>Met variant to 1.7-A resolution. por James A. Hamilton, L. K. Steinrauf, Bradford C. Braden, J. J. Liepnieks, M D Benson, Gösta Holmgren, O Sandgren, Lars Steen
Publicado 1993Artigo -
15
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia. por A C Moses, Harold N. Rosen, David E. Moller, S. Tsuzaki, James E. Haddow, Jennifer Lawlor, J. J. Liepnieks, William C. Nichols, M D Benson
Publicado 1990Artigo -
16
Application of the Behaviour Change Wheel to Promote Utilisation of a Cognitive Impairment Screening Tool por Isabel Zbukvic, Shayden Bryce, Vita Pilkington, R. G. J. Mills, Desiree Smith, L.D. Alahakoon, Caroline Crlenjak, M. D. Benson, Jacinta Delprado, Jody Kamminga, Kelly Allott
Publicado 2025Artigo -
17
Intracellular Ferritin Accumulation in Neural and Extraneural Tissue Characterizes a Neurodegenerative Disease Associated with a Mutation in the<i>Ferritin Light Polypeptide</i>Gen... por Rubén Vidal, Bernardino Ghetti, Masaki Takao, Christine Brefel‐Courbon, Emmanuelle Uro‐Coste, Bradley S. Glazier, V. Siani, M D Benson, P. Calvas, Leticia Miravalle, Olivier Rascol, Marie B. Delisle
Publicado 2004Artigo -
18
PS1221 LONG‐TERM EFFICACY AND SAFETY OF INOTERSEN FOR HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: NEURO‐TTR OPEN‐LABEL EXTENSION 2‐YEAR UPDATE por T.H. Brannagan, Márcia Waddington‐Cruz, A.K. Wang, Michael Polydefkis, P. James B. Dyck, Sami Khella, Violaine Planté‐Bordeneuve, J.L. Burk, Fábio Barroso, Giampaolo Merlini, Isabel Conceição, Steven G. Hughes, Jesse Kwoh, Shiangtung W. Jung, S. Guthrie, Murray Pollock, M D Benson, MorieA Gertz, T. Coelho
Publicado 2019Artigo -
19
Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial... por Thomas H. Brannagan, A. K. Wang, Teresa Coelho, Márcia Waddington‐Cruz, Michael Polydefkis, P. James B. Dyck, Violaine Planté‐Bordeneuve, John L. Berk, Fábio Barroso, Giampaolo Merlini, Isabel Conceição, Stephen G. Hughes, Jesse Kwoh, Shiangtung W. Jung, Spencer Guthrie, M. Pollock, M. D. Benson, Morie A. Gertz
Publicado 2020Artigo
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Biology
Amyloidosis
Gene
Transthyretin
Biochemistry
Internal medicine
Chemistry
Endocrinology
Molecular biology
Amyloid (mycology)
Genetics
Pathology
Immunology
Mutation
Peptide sequence
Amino acid
Disease
Inorganic chemistry
Adverse effect
Antibody
Cell biology
Cyanogen bromide
Enzyme
Inflammation
Neuroscience
Oncology
Physics
Point mutation
Polyneuropathy